Moreover, most recent clinical observations revealed that breast carcinoma patients with low IR expression levels had significantly longer progression-free survival and overall survival [10], while presence of phosphorylated INSR/IGF1R is related to poor survival in all breast cancer subtypes [11]. The gene discussed is INSR; the disease is breast carcinoma.